NNIT to ride Danish wave to IPO after Matas success
Pharmaceuticals firm Novo Nordisk said on Wednesday that it would list NNIT, an information technology subsidiary, seeking to take advantage of growing appetite for Danish stocks. The country is also seeing smaller firms looking to come to market for the first time in many years.
`NNIT is likely to be valued at around Dkr4bn-Dkr5bn ($732m-$915m) through the deal, with Novo Nordisk listing around a third of the company. The company generates Ebitda of around Dkr350m, with around 50% of its revenues coming from Novo Nordisk.
Local market participants identified NNTI as one company
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: firstname.lastname@example.org
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: email@example.com or find out more online here.